Background: Essential tremor (ET) is a common movement disorder characterized by kinetic and postural tremor in the upper extremities and frequently in the midline.
Introduction
Essential tremor (ET) is a prevalent movement disorder that affects approximately 7 million people in the United States. 1 ET is classically characterized by the presence of upper extremity kinetic and postural tremor. However, motor symptoms in ET extend beyond the upper extremities. Persons with ET also commonly exhibit axial motor symptoms, notably midline tremor 2 (e.g., tremor of the head, jaw, voice, or trunk) and gait ataxia [3] [4] [5] in addition to occasional nonmotor symptoms. 6 Several studies have reported associations between midline tremor and gait impairment in persons with ET, 5, 7, 8 collectively suggesting that the pathophysiology underlying these symptoms may be distinct from the pathophysiology underlying upper extremity tremor. 9 These studies provided correlational evidence relating clinical tremor scores to common measures of gait ataxia (e.g., number of missteps during tandem walking, step width, step-to-step variability). However, a causal relationship between midline tremor severity and gait impairment in ET has not been established.
In this study, we assessed tremor, gait, and tandem gait in persons with medication-refractory ET before and after unilateral implantation of thalamic deep brain stimulation (DBS), a proven treatment approach for reducing upper extremity and midline tremor [10] [11] [12] [13] in ET. We aimed to understand whether improvement in midline tremor following DBS was related to gait improvement in persons with ET. Based on prior work, 5, 7, 8, 9 we hypothesized that improvement in midline -but not upper extremity -tremor would be associated with gait improvement following DBS.
Methods

General methods
Seven persons with ET and 17 persons with ET plus (due to the presence of ET and tandem gait impairment 14 ) participated (mean±standard deviation age: 68 ± 6 years, sex: 16M/8F). ET diagnosis was confirmed by standardized criteria 14 and evaluation by a fellowship-trained movement disorders neurologist. As part of our Center's standard of care, we perform a staged DBS surgery. The second DBS surgery was performed in an identical but staged fashion with a delay of at least 6 months between sides. Participants performed gait and clinical assessments on two separate days. The first day occurred approximately 3 months prior to undergoing unilateral DBS implantation into the ventralis intermedius nucleus of the thalamus (PRE). The second day occurred approximately 6 months following surgery and consisted of two testing sessions: one with the stimulation off (OFF) and one with the stimulation on at optimized parameters (ON). Details about the surgical procedure have been reported previously. 15 The stimulation was deactivated at least 1 hour prior to the OFF testing and activated at least 1 hour prior to the ON testing. Prior to each gait assessment, a movement disorders neurologist assessed tremor severity using the motor portion (items 1-14) of the Fahn-Tolosa-Marin Tremor Rating Scale (TRS). 16 All participants provided written consent as approved by the University of Florida Institutional Review Board.
Gait analysis
Participants underwent gait assessments using a three-dimensional, ten-camera motion capture system (120 Hz; Vicon Nexus, Vicon, Oxford, UK). Participants wore 35 passive retroreflective markers placed in accordance with the Vicon Plug-in-Gait full body marker set. Participants performed 5-10 normal walking trials along an 8-m walkway. Twenty-two of the participants also performed five tandem walking trials along the same walkway. All trials were performed at self-selected speeds.
Walking speed, step length, step time, and step width were calculated for the normal walking trials using conventional definitions. 17 We calculated the mean and a measure of variability (coefficient of variation: CV=standard deviation/mean) for each parameter. During tandem walking trials, we calculated mean walking speed and percentage of steps when a misstep occurred. A misstep was defined by two or more consecutive steps with the same foot.
Clinical assessment
We calculated motor TRS score as the sum of TRS subitems 1-14 (including all resting, postural, and kinetic scores), midline TRS score as the sum of TRS subitems 1-4 and 7 (including all resting, postural, and kinetic scores), and kinetic TRS score as the sum of TRS subitems 5, 6, 8, and 9 (including kinetic scores only).
Statistical analysis
We performed repeated measures ANOVAs (with Bonferroni post hoc corrections for multiple comparisons, where appropriate) to compare TRS scores (motor, midline, and kinetic), gait measures, and tandem gait measures among sessions (PRE, OFF, ON). We also performed two sets of Pearson's correlations. First, we performed Pearson's correlations to assess relationships between TRS scores (motor, midline, and kinetic) and gait parameters (walking speed, step length, step time, step width, step length CV, step time CV, step width CV, tandem missteps, and tandem walking speed) at baseline (PRE). Next, we performed Pearson's correlations to assess relationships between changes in TRS scores (motor, midline, kinetic) and changes in gait parameters (walking speed, step length, step time, step width, step length CV, step time CV, step width CV, tandem missteps, and tandem walking speed) from PRE to ON (change scores calculated as ON minus PRE). We performed all tests with α = 0.05 and performed Shapiro-Wilk tests for normality and Mauchly's tests of sphericity on all variables. Greenhouse-Geisser corrections were used when sphericity was violated. We performed all analyses using SPSS software (IBM SPSS Statistics 25, Armonk, NY).
Results
Efficacy of DBS for tremor suppression and effects of DBS on gait
As previously reported, 15 we observed significant main effects of condition on all TRS scores (motor, midline, and kinetic) and also step time CV (all p < 0.01). Post hoc analyses revealed that the motor, midline, and kinetic TRS scores improved significantly when ON as compared to PRE (all p < 0.03) and OFF (all p < 0.01). TRS scores were not significantly different between PRE and OFF.
We also observed a significant main effect of condition on step time CV (p < 0.001). Post hoc analyses revealed a significant increase in step time CV from PRE to ON (p = 0.001), indicating that step times were more variable during ON than PRE. There were no significant differences in walking speed, step length, step time, step width, step length CV, step width CV, tandem walking speed, or tandem missteps among conditions (all p > 0.05). These TRS and gait data were reported previously 15 and are included here only to establish that DBS caused the expected suppression of midline tremor but minimal change in gait at the cohort level.
Relationships between tremor severity and gait at baseline
At baseline (PRE), we did not observe significant relationships between any measures of normal or tandem gait and motor TRS, midline TRS, or kinetic TRS scores (Table 1 ; all p > 0.05).
Relationships between changes in midline tremor severity and changes in gait following DBS
We did not observe significant relationships between changes in mean gait parameters (walking speed, step length, step time, step width, and tandem gait measures) and changes in midline TRS scores from PRE to ON (Figure 1 ). When assessing relationships between changes in gait variability (step length CV, step time CV, and step width CV) and Table 1 
. Baseline (PRE) relationships between Fahn-Tolosa-Marin Tremor Rating Scale (TRS) subscores and gait parameters
Motor TRS Midline TRS Kinetic TRS
Walking speed (m/s) r=0.01, p=0.95 r=0.31, p=0.14 r=-0.11, p=0.60
Step length (m) r=0.10, p=0.63 r=0.31, p=0.14 r=-0.09, p=0.68
Step time (s) r=0.11, p=0.62 r=-.13, p=0.55 r=0.05, p=0.81
Step width (m) r=0. 14 changes in midline TRS scores, we observed only a significant negative relationship between changes in step time CV and midline TRS score (r = −0.42, p = 0.04; Figure 2 ).
Discussion
ET is a common movement disorder characterized by kinetic and postural tremor of the upper extremities. Persons with ET also frequently exhibit midline tremor and gait ataxia. Previous findings indicated that midline tremor severity and gait dysfunction may be linked in persons with ET. We tested this directly in persons with medicationrefractory ET who underwent unilateral thalamic DBS to improve tremor. Midline tremor showed significant improvement following DBS; however, gait was unaffected at the cohort level. Contrary to our hypothesis, midline tremor improvement showed no significant association with gait improvement. Our results demonstrated that improvement in midline tremor occurred independently of changes in walking in persons with ET, suggesting that these symptoms are dissociable.
Previous studies have suggested that a link between midline tremor severity and gait ataxia could represent a shared pathophysiology between these symptoms that is distinct from the pathophysiology underlying upper extremity tremor. 9 More specifically, midline tremor and gait ataxia have been hypothesized to be caused by dysfunction in cerebellar regulation of axial motor control. 9 This hypothesis is bolstered by many studies that observed Purkinje cell dysfunction [18] [19] [20] [21] [22] [23] [24] [25] and cerebellar-like gait disturbances 7,26-29 in persons with ET. Our results do not question the potential cerebellar origin of motor control deficits in ET; however, they do suggest that these deficits can be differentially modulated with unilateral stimulation of the ventralis intermedius nucleus of the thalamus.
Our results are supported by prior studies of motor outcomes following unilateral thalamic DBS for ET. Prior work has shown that unilateral thalamic DBS improves midline tremor in persons with ET. [11] [12] [13] 30 However, the gait response to DBS has been much less consistent. 31 Some evidence supports gait improvement following thalamic DBS for ET, 32,33 but gait worsening is more commonly reported. 13, 15, 34, 35 Furthermore, one of the studies that observed gait improvement also revealed that the gait benefits occurred independently of changes in tremor. 30 In sum, current evidence suggests that the gait response to thalamic DBS for ET varies regardless of the reliable improvement in upper extremity and midline tremor.
It is also notable that our study did not observe relationships between midline tremor severity and gait impairment at baseline as have been previously reported. 4,7-9 Our study differs from previous studies in several ways. The gait data presented here were collected in a gait laboratory using three-dimensional motion capture instead of clinical gait assessments. We assessed midline tremor severity using the Fahn-Tolosa-Marin TRS rather than a binary tremor score. Our sample size is smaller than previous studies; however, even with a smaller sample size, we observed robust, significant improvement in tremor following DBS that was not accompanied by gait improvement.
Our study had several limitations. We recruited participants based on a convenience sample of patients wishing to undergo DBS implantation at a single center. We did not select participants based on severity of midline tremor or gait ataxia. DBS parameters were set to optimize tremor reduction and were not set with the goal of gait improvement. Further studies are needed to clarify the difference of stimulation parameters between tremor reduction and gait improvement. Our study included only participants with unilateral DBS. Prior work suggests that bilateral DBS may have stronger effects on gait and balance. 34 We only tested participants at two time points. It is possible that tremor and gait impairment in ET have a shared pathophysiology, but gait features become gradually unresponsive to DBS. Studies that include a longer follow-up period may dissociate effects of disease progression and long-term efficacy of DBS. However, the lack of differences between PRE and OFF suggests that disease progression (over approximately 9 months) was unlikely to be a major factor in our results. Finally, we measured only spatiotemporal features of walking and did not include kinematic or kinetic measurements.
Despite these limitations, we found upper extremity and midline tremor severity improved significantly following DBS, while gait was not significantly affected at the cohort level. Improvement in midline tremor was not significantly associated with the improvement in gait following DBS. Our study offers evidence that gait impairment can be dissociated from tremor in persons with ET. Future prospective studies should examine the underlying causes of gait impairment in ET and its lack of responsiveness to DBS.
